Epstein Secrets

ent on TPP at the Obama/Abe press conference as well as de-risking ahead of tomorrow's Tokyo CPI numbers as reasons for the weakness. Australia and New Zealand were modestly firmer ahead of tomorrow's closure for ANZAC Day. The RBNZ raised the Official Cash Rate by 25bps to 3% as expected. India was closed

ar, LFL's strong (trading -0.16%) • Astrazeneca eps slightly lower than estimates, maintains guidance, pipeline update positive (trading +4.0%) • Novartis O1 core eps and net meet estimates, fx impact, sales miss, guidance reiterated (trading -1.1%) • Novozymes Q1 beats estimates, now sees 2014 net pr

ous AEs were reported. A randomized, double- blind, placebo-controlled trial to extend these findings to a larger population is ongoing in Australia, New Zealand, and the U.S. Figure 130 ZYNOO2 Produced Reductions In ADAMS At 12 Weeks... Figure 131 ...And Efficacy Persisted Out To 12 Months In An Extension St

Marley Natural, Irisa, Goodship, Grail, and Dutchy. TLRY has been active on the M&A front, with previously announced acquisitions / partnerships with Novartis, Authentic Brands and AB-Inbev, among others. Most recently, the company announced a C$419 mm acquisition of Manitoba Harvest, the global leader in h

under the Ordinance. This confidential private placement memorandum has not been submitted to or approved by the Netherlands Antilles Central Bank New Zealand Notice to Investors In New Zealand The provision of this document to any person does not constitute an offer of interests to that person or an inv

s, improving their effectiveness but shrinking their addressable markets. Drug companies will need to adapt their marketing strategies accordingly. Novartis CEO Joe Jimenez called out the explosion in DNA sequencing as a driver for R&D productivity "allowing new areas of discovery that have never been po